Trial intelligence / Profile preview

Ondansetron Lozenge vs IV for Shivering Prevention in Tonsillectomy

NCT07489742Recruiting

Sponsor
Tanta University
Start
Mar 2026
Primary completion
Sep 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ondansetron (3 arms), sponsored by Tanta University. Primary endpoint: Incidence of shivering. Started Mar 2026; status: recruiting.

02

Drugs

ondansetron

Beyond the preview

Go deeper on NCT07489742.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07489742.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call